March 15, 2022 Ryvu Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update
Read More
March 8, 2022 Ryvu Therapeutics to Present Data from its Oncology Programs at AACR 2022 Annual Meeting
Read More
January 17, 2022 Ryvu Therapeutics appoints Hendrik Nogai, M.D. as Chief Medical Officer
Read More
January 3, 2022 Ryvu Therapeutics to participate in the LifeSci Partners 11th Annual Corporate Access Event and H.C. Wainwright Bioconnect Conference
Read More
Posts navigation
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. Ok Privacy policy